Why should pharma invest in digital products for those living with rare diseases?
pharmaphorum
NOVEMBER 23, 2022
Research in rare diseases will benefit from identifying cause and effect, which consider behaviours, social economics, and the patient’s emotional state. New digital products always rely on early adopters to create a community and improve the product. A proactive and passionate community. Create a human experience of care.
111 
Let's personalize your content